What's new

Human medicines European public assessment report (EPAR): Beovu, brolucizumab, Date of authorisation: 13/02/2020, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Beovu, brolucizumab, Date of authorisation: 13/02/2020, Revision: 16, Status: Authorised

May 19, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Beovu, brolucizumab, Date of authorisation: 13/02/2020, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Beovu, brolucizumab, Date of authorisation: 13/02/2020, Revision: 16, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya va...

Next Article

Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisati...

Related Posts

Human medicines European public assessment report (EPAR): Targretin, bexarotene, Date of authorisation: 29/03/2001, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Deqsiga, human normal immunoglobulin, Date of authorisation: 02/05/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0

European Shortages Monitoring Platform (ESMP) essential...

May 13, 2025  0